Reata Pharmaceuticals, Inc. which can be found using ticker (RETA) have now 10 confirmed analysts covering the stock with the consensus suggesting a rating of ‘buy’. The target price High/Low ranges between 179 and 80 with the average target price sitting at $112.70. Now with the previous closing price of $79.98 this is indicating there is a potential upside of 40.9%. The day 50 moving average is $92.72 and the 200 day MA is $50.50. The company has a market capitalization of 2.98B. The stock price is currently at: 79.42 USD
The potential market cap would be $4,202,411,033 based on the market consensus.
USD
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of -, revenue per share of 0.04 and a -35.78% return on assets.
